Roche Holding AG: Number of Employees 2010-2024 | RHHBY

Interactive chart of Roche Holding AG (RHHBY) annual worldwide employee count from 2010 to 2024.
  • Roche Holding AG total number of employees in 2024 was 103,249, a 0.34% decline from 2023.
  • Roche Holding AG total number of employees in 2023 was 103,605, a 0.01% decline from 2022.
  • Roche Holding AG total number of employees in 2022 was 103,613, a 2.67% increase from 2021.
  • Roche Holding AG total number of employees in 2021 was 100,920, a 0.54% decline from 2020.
Roche Holding AG Annual Employee Count
2024 103,249
2023 103,605
2022 103,613
2021 100,920
2020 101,465
2019 97,735
2018 94,442
2017 93,734
2016 94,052
2015 91,747
2014 88,509
2013 85,080
2012 82,089
2011 76,911
2010 80,653
2009 N/A
Sector Industry Market Cap Revenue
Medical Large Cap Pharmaceutical $255.245B $68.726B
Basel, Switzerland-based Roche Holding Ltd. is a leading health care company focused on developing and commercializing innovative diagnostic and therapeutic products and services, which enable early detection and prevention of diseases as well as their treatment and monitoring. The company conducts its operations through two segments ' Pharmaceuticals and Diagnostics.Pharmaceuticals: Key focus areas in this segment include Oncology, Virology, Inflammation, Metabolism and Neuroscience. Diagnostics: The Diagnostics Division operates in four segments ' Roche Professional Diagnostics, Roche Diabetes Care, Roche Molecular Diagnostics, and Roche Tissue Diagnostics. In September 2014, Roche acquired InterMune for $8.3 billion and added Esbriet to its portfolio. During the first quarter of 2018, Roche acquired Flatiron Health and Ignyta, Inc.
Stock Name Country Market Cap PE Ratio
Eli Lilly (LLY) United States $749.886B 57.50
Johnson & Johnson (JNJ) United States $366.637B 15.16
AbbVie (ABBV) United States $327.632B 18.06
Novartis AG (NVS) Switzerland $245.907B 14.04
Merck (MRK) United States $196.564B 10.05
Pfizer (PFE) United States $136.449B 7.48
Sanofi (SNY) France $118.258B 11.65
Bayer (BAYRY) Germany $30.298B 6.17
Innoviva (INVA) United States $1.346B 14.10
Novo Nordisk (NVO) Denmark $0.000B 21.99